No long-term hard-outcome data
Considering all factors combineda robust profile encompassing efficiency plus added health improvementsTirzepatide maintains its standing as a powerful option within the pharmaceutical choices available today
Lipotropic injections are designed to aid in fat breakdown, aid your metabolism and support long-term weight management
Book Your Free Virtual Consultation Today
The second was a summary sheet containing information on country, study phase, dose, duration, inclusion and exclusion criteria, outcomes, and conclusion
Trials still pending Two core obesity trials are still running: TRIUMPH-2 (obesity + type 2 diabetes) results expected later 2026 TRIUMPH-3 (obesity + established cardiovascular disease) results expected later 2026 A separate cardiovascular outcomes trial, TRIUMPH-Outcomes (~10,000 patients), is not required for the initial obesity NDA and wont report until 20282029